Browse By Person: Doggrell, Sheila

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 182.

Book

Doggrell, Sheila, Davis, Elizabeth, Hart, Joanne, Hinton, Tina, & Johnston, Graham (2015) Pharmacology in one semester [Version 3, Semester 1, 2014]. Google.
Number of full-text downloads 140

Doggrell, Sheila, Davis, Elizabeth, Hart, Joanne, Hinton, Tina, Johnson, Graham, & Mullaney, Ian (2012) Pharmacology in one semester. Sheila Doggrell.
Number of full-text downloads 1,118

Book Chapter

Doggrell, Sheila Anne (2017) Introduction to pharmacology, and routes of drugs administration and absorption. In Pharmacology in One Semester [Version 4]. Queensland University of Technology, Brisbane, Qld.
Number of full-text downloads 12

Doggrell, Sheila & Davis, Elisabeth (2012) Anti-infectives. In Doggrell, Sheila (Ed.) Pharmacology in One semester.
Number of full-text downloads 123

Doggrell, Sheila (2012) Drug development. In Phamacology in one semester. Doggrell, Sheila.
Number of full-text downloads 84

Doggrell, Sheila (2012) Drug distribution, metabolism and elimination, and relationship to blood levels. In Doggrell, Sheila (Ed.) Pharmacology in one semester. eBook.
Number of full-text downloads 174

Doggrell, Sheila & Hart, Joaane L. (2012) Drugs Used to Treat Endocrine Disorders. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
Number of full-text downloads 186

Doggrell, Sheila (2012) Drugs and the autonomic nervous system. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
Number of full-text downloads 209

Doggrell, Sheila (2012) Drugs and the respiratory system. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
Number of full-text downloads 200

Doggrell, Sheila (2012) Introduction to pharmacology, and routes of drug administration. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Sheila Doggrell.
Number of full-text downloads 500

Doggrell, Sheila (2012) Neurological drugs and opioids for pain management. In Doggrell, Sheila (Ed.) Pharmacology in One semester.
Number of full-text downloads 121

Doggrell, Sheila (2012) Pharmacodynamics. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Doggrell, Sheila.
Number of full-text downloads 114

Doggrell, Sheila (2012) Pharmacovigilance and pharmacogenetics. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Doggrell, Sheila.
Number of full-text downloads 119

Doggrell, Sheila (2012) Poisoning with drugs. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Doggrell, Sheila.
Number of full-text downloads 64

Doggrell, Sheila (2012) Smoking cessation. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
Number of full-text downloads 79

Journal Article

Doggrell, Sheila Anne & Schaffer, Sally (2016) Reduced withdrawal and failure rates of accelerated nursing students enrolled in pharmacology is associated with a supportive intervention. BMC Medical Education, 16, Article Number 40.
Number of full-text downloads 26

Doggrell, Sheila Anne & Schaffer, Sally (2016) Attrition and success rates of accelerated students in nursing courses: A systematic review. BMC Nursing, 15, Article Number-24.
Number of full-text downloads 94

Doggrell, Sheila & Dimmitt, Simon B. (2016) Sitagliptin and other ‘gliptins’ - why prescribe them? Expert Opinion on Pharmacotherapy, 17(6), pp. 757-760.
Number of citations in Scopus 1

Doggrell, Sheila A. (2015) Ongoing poor management of medicines in the older-aged living independently in a rental retirement village. International Journal of Clinical Pharmacy, 37(6), pp. 1000-1003.
Number of full-text downloads 7
Number of citations in Scopus 1

Doggrell, Sheila Anne & Chan, Vincent (2015) Adherence to insulin treatment in diabetes: Can it be improved? Journal of Diabetes, 7(3), pp. 315-321.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2015) Are we waiting too long for the cardiovascular outcome trials with the glucagon-like peptide-1 receptor agonists? Expert Opinion on Drug Safety, 14(6), pp. 801-805.
Number of full-text downloads 18
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Doggrell, Sheila (2015) After 10 years of clinical trials with liraglutide, do we know whether it is beneficial in diabetes? Review of Recent Clinical Trials, 10(1), pp. 68-77.

Doggrell, Sheila (2015) Comparator clinical trials of surrogate endpoints with albiglutide are in HARMONY. Expert Review of Endocrinology & Metabolism, 10(3), pp. 273-276.
Number of full-text downloads 6

Doggrell, Sheila Anne & Lynch, Kaileen Anne (2015) Is there enough evidence with evolocumab and alirocumab (antibodies to proprotein convertase substilisin-kexin type, PCSK9) on cardiovascular outcomes to use them widely? Expert Opinion on Biological Therapy, 15(12), pp. 1671-1675.
Number of full-text downloads 5
Number of citations in Web of Science® 1

Doggrell, Sheila A. & Tuli, Rinku (2014) Dapagliflozin – do we need it registered for type 2 diabetes? Expert Opinion on Pharmacotherapy, 15(11), pp. 1631-1635.
Number of full-text downloads 46
Number of citations in Scopus 1
Number of citations in Web of Science® 2

Doggrell, Sheila A (2014) Not so critical appraisal of dapagliflozin. Patient Preference and Adherence, 8, pp. 1101-1104.
Number of full-text downloads 103

Doggrell, S. A. & Chan, V. (2014) Do interventions by allied health professionals discussing adherence to insulin improve this adherence? Diabetes research and clinical practice, 104(3), e61-e63.
Number of full-text downloads 42

Doggrell, Sheila & Warot, Servane (2014) The association between the measurement of adherence to anti-diabetes medicine and the HbA1c. International journal of clinical pharmacy, 36(3), pp. 488-497.
Number of full-text downloads 41
Number of citations in Scopus 12
Number of citations in Web of Science® 8

Doggrell, Sheila A. & Dimmitt, Simon B. (2014) Gliptins - do they increase cardiovascular risk or benefit? Expert opinion in drug safety, 13(5), pp. 675-680.
Number of full-text downloads 57
Number of citations in Scopus 9
Number of citations in Web of Science® 7

Doggrell, Sheila A. (2014) Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin. Patient Preference and Adherence, 2014(8), pp. 473-475.
Number of full-text downloads 20
Number of citations in Web of Science® 1

Doggrell, Sheila & McIntyre, Kerry (2014) Canagliflozin : something new for type 2 diabetes, but is it safe and efficacious? Expert Opinion on Pharmacotherapy, 15(3), pp. 437-441.
Number of full-text downloads 375
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila A & Hancox, Jules C (2014) Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicine. Expert Opinion on Drug Safety, 13(1), pp. 131-138.
Number of full-text downloads 175
Number of citations in Scopus 20
Number of citations in Web of Science® 17

Doggrell, Sheila & Kairuz, Therese (2014) Comparative studies of how living circumstances influence medication adherence in ≥ 65 year olds. International Journal of Clinical Pharmacy, 36(1), pp. 30-35.
Number of full-text downloads 18
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Doggrell, Sheila Anne (2013) Comment on: Clinical benefits of ezetimibe : absence of proof is just that. Expert Opinion on Pharmacotherapy, 14(18), pp. 2611-2613.
Number of full-text downloads 30
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila Anne (2013) Inadequate management of medicines by the older-aged living in a retirement village. International Journal of Clinical Pharmacy, 35(4), pp. 546-549.
Number of full-text downloads 39
Number of citations in Scopus 4
Number of citations in Web of Science® 3

Doggrell, Sheila A & Hancox, Jules C (2013) Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia. Expert Opinion on Drug Safety, 12(3), pp. 421-431.
Number of full-text downloads 144
Number of citations in Scopus 7
Number of citations in Web of Science® 5

Doggrell, Sheila A (2013) Exenatide extended-release; clinical trials, patient preference, and economic considerations. Patient Preference and Adherence, 7, pp. 35-45.
Number of full-text downloads 152
Number of citations in Scopus 7
Number of citations in Web of Science® 3

Doggrell, Sheila Anne & Chan, Vincent (2012) Bariatric surgery or medicine for type 2 diabetes? Expert Opinion on Pharmacotherapy, 13(15), pp. 2249-2253.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila A. (2012) More light at the end of the tunnel – apixaban in atrial fibrillation. Expert Opinion in Investigational Drugs, 21(8), pp. 1235-1239.
Number of full-text downloads 145
Number of citations in Scopus 1

Doggrell, Sheila & Hancox, Jules (2012) PALLAS : limiting indications for dronedarone treatment of atrial fibrillation. Expert Opinion on Pharmacotherapy, 13(6), pp. 867-871.
Number of full-text downloads 34
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2012) Dalcetrapib restoring belief in modulating CETP as a beneficial mechanism in cardiovascular disease. Expert Opinion in Investigational Drugs, 21(4), pp. 569-573.
Number of full-text downloads 101
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila & Kairuz, Therese (2012) Medicine management by the older-aged living independently in different types of retirement villages. Journal of Pharmacy Practice and Research, 42, pp. 208-212.
Number of full-text downloads 149
Number of citations in Scopus 5

Doggrell, Sheila (2012) The ezetimibe controversy? Can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together? Expert Opinion on Pharmacotherapy, 13(10), pp. 1469-1480.
Number of full-text downloads 140
Number of citations in Scopus 10
Number of citations in Web of Science® 12

Doggrell, Sheila (2011) Adherence to oral endocrine treatments in women with breast cancer: can it be improved? Breast Cancer Research and Treatment, 129(2), pp. 299-308.
Number of citations in Scopus 13
Number of citations in Web of Science® 12

Doggrell, Sheila & Christensen, Anne-Marie (2011) Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib? Expert Opinion on Pharmacotherapy, 12(1), pp. 157-163.
Number of citations in Scopus 4
Number of citations in Web of Science® 3

Doggrell, Sheila (2011) Bitter taste receptors as a target for bronchodilation. Expert Opinion on Therapeutic Targets, 15(7), pp. 899-902.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2011) CX3CR1 as a target for airways inflammation. Expert Opinion on Therapeutic Targets, 15(9), pp. 1139-1142.
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Doggrell, Sheila (2011) Is there evidence to support the use of direct Factor Xa inhibitors in coronary artery disease? Reviews on Recent Clinical Trials, 6(2), pp. 147-157.
Number of citations in Scopus 3

Doggrell, Sheila (2011) Lemur tyrosine kinase-3 (LMTK3) as a target in oestrogen positive breast cancer. Expert Opinion on Therapeutic Targets, 15(12), pp. 1419-1422.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2011) Lowering LDL cholesterol with margarine containing plant stanol/sterol esters: Is it still relevant in 2011? Complementary Therapies in Medicine, 19(1), pp. 37-46.
Number of citations in Scopus 6
Number of citations in Web of Science® 4

Doggrell, Sheila (2011) Sitagliptin or exenatide once weekly for type 2 diabetes: Comparison of the clinical trials. Expert Opinion on Pharmacotherapy, 12(13), pp. 2055-2067.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2011) Treatment for relapsed Hodgkin lymphoma: Refinement of chemotherapy or targeted treatment? Expert Opinion on Pharmacotherapy, 12(6), pp. 991-994.

Doggrell, Sheila (2011) A new approach to Parkinson's disease: inhibition of leucine-rich repeat kinase-2. Expert Opinion on Investigational Drugs: authoritative analysis of R&D trends, 20(4), pp. 587-590.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila Anne (2010) Resolvin inflammation with pain. Expert Opinion on Investigational Drugs, 19(11), pp. 1461-1464.
Number of full-text downloads 129
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila Anne (2010) Oral fingolimod for relapsing-remitting multiple sclerosis. Expert Opinion on Pharmacotherapy, 11(10), pp. 1777-1781.
Number of full-text downloads 21
Number of citations in Scopus 7
Number of citations in Web of Science® 4

Doggrell, Sheila (2010) Zoledronic acid once-yearly : what role in the prevention of non-vertebral osteoporotic fractures? Clinical Medicine Insights: Therapeutics, 2010(2), pp. 539-547.
Number of full-text downloads 453

Doggrell, Sheila Anne (2010) The hedgehog pathway inhibitor GDC-0449 shows potential in skin and other cancers. Expert Opinion on Investigational Drugs, 19(3), pp. 451-454.
Number of full-text downloads 249
Number of citations in Scopus 10
Number of citations in Web of Science® 10

Doggrell, Sheila (2010) Does intervention by an allied health professional discussing adherence to medicines improve this adherence in Type 2 diabetes? Diabetic Medicine: journal of diabetes UK, 27(12), pp. 1341-1349.
Number of citations in Scopus 8
Number of citations in Web of Science® 7

Doggrell, Sheila Anne & Christensen, Anne-Marie (2010) Does the p38 MAP kinase inhibitor pamapimod have potential for the treatment of rheumatoid arthritis? Expert Opinion on Pharmacotherapy, 11(14), pp. 2437-2442.
Number of full-text downloads 140
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Doggrell, Sheila (2010) New drugs for the treatment of coronary artery syndromes. Expert Opinion on Pharmacotherapy, 11(2), pp. 325-329.
Number of full-text downloads 228

Hancox, Jules & Doggrell, Sheila (2010) Perspective: Does ranolazine have potential for the treatment of atrial fibrillation? Expert Opinion on Investigational Drugs, 19(12), pp. 1465-1474.
Number of citations in Scopus 4
Number of citations in Web of Science® 4

Doggrell, Sheila (2009) Is liraglutide or exenatide better in type 2 diabetes? Expert Opinion on Pharmacotherapy, 10(16), pp. 2769-2772.
Number of full-text downloads 737
Number of citations in Scopus 3

Doggrell, Sheila (2009) Anti-cancer activity of zoledronic acid in breast cancer. Expert Opinion on Pharmacotherapy, 10(14), pp. 2387-2390.

Doggrell, Sheila (2009) Clinical efficacy and safety of zoledronic acid in osteoporosis and Paget's disease. Expert Review of Endocrinology and Metabolism, 4(5), pp. 405-415.

Doggrell, Sheila (2009) Clinical efficacy and safety of zoledronic acid in prostate and breast cancer. Expert Review of Anticancer Therapy, 9(9), pp. 1211-1218.
Number of full-text downloads 364
Number of citations in Scopus 17
Number of citations in Web of Science® 13

Doggrell, Sheila (2009) Good clinical endpoints with denosumab in osteoporosis and cancer. Expert Opinion in Pharmacotherapy, 10(17), pp. 2939-2943.
Number of full-text downloads 150

Doggrell, Sheila (2009) Lyprinol : is it a useful anti-inflammatory agent? Evidence Based Complementary and Alternative Medicine.
Number of full-text downloads 1,067
Number of citations in Scopus 7
Number of citations in Web of Science® 5

Doggrell, Sheila (2009) New findings with old drugs for osteoporosis. Expert Opinion on Pharmacotherapy, 10(3), pp. 513-516.
Number of full-text downloads 182
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2009) Telcagepant is a new oral treatment for migraine. Expert Opinion in Pharmacotherapy, 10(9), pp. 1523-1526.
Number of full-text downloads 265
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2009) Tesofensine : a novel potent weight loss medicine. Expert Opinion in Investigational Drugs, 18(7), pp. 1043-1046.
Number of full-text downloads 636
Number of citations in Scopus 7
Number of citations in Web of Science® 6

Doggrell, Sheila (2008) What is the future for rimonabant in the treatment of obesity. Review of Endocrinology, December, pp. 14-17.

Doggrell, Sheila (2008) Celecoxib to prevent restenosis - results from the COREA-TAXUS trial. Expert Opinion on Pharmacotherapy, 9(2), pp. 339-341.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2008) Clinical trials with thiazolidinediones in subjects with Type 2 diabetes - is pioglitazone any different from rosiglitazone? Expert Opinion on Pharmacotherapy, 9(3), pp. 405-420.
Number of citations in Scopus 17
Number of citations in Web of Science® 18

Doggrell, Sheila (2008) Is long-term adjuvant treatment of breast cancer with anastrozole indicated? Expert Opinion on Pharmacotherapy, 9(9), pp. 1619-1622.
Number of citations in Scopus 3
Number of citations in Web of Science® 1

Doggrell, Sheila (2008) Is rimonabant efficacious and safe in the treatment of obesity? Expert Opinion on Pharmacotherapy, 9(15), pp. 2727-2731.
Number of citations in Scopus 19
Number of citations in Web of Science® 16

Doggrell, Sheila (2008) Is sapropterin treatment suitable for all subjects with phenylketonuria? Expert Opinion on Pharmacotherapy, 9(1), pp. 145-147.
Number of citations in Scopus 5
Number of citations in Web of Science® 2

Doggrell, Sheila (2008) Is tocilizumab an option for the treatment of arthritis? Expert Opinion on Pharmacotherapy, 9(11), pp. 2009-2013.

Doggrell, Sheila (2008) New indications for topiramate: alcohol dependency and binge-eating disorder. Expert Opinion on Pharmacotherapy, 9(5), pp. 869-873.
Number of citations in Scopus 4
Number of citations in Web of Science® 1

Doggrell, Sheila (2008) Therapeutic potential of non-peptide chymase inhibitors. Expert Opinion on Therapeutic Patents, 18(5), pp. 485-499.
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Doggrell, Sheila (2007) Cardiovascular and renal effects of nociceptin/orphanin FQ: a new mediator to target? Current Opinion in Investigational Drugs, 8(9), pp. 742-749.
Number of citations in Scopus 8
Number of citations in Web of Science® 5

Doggrell, Sheila (2007) Clopidogrel use with stenting. Expert Opinion on Pharmacotherapy, 8(9), pp. 1399-1402.
Number of citations in Scopus 1
Number of citations in Web of Science® 2

Doggrell, Sheila (2007) Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction? International Journal of Impotence Research, 19(3), pp. 281-295.
Number of citations in Scopus 26
Number of citations in Web of Science® 22

Doggrell, Sheila (2007) Does rosiglitazone increase cardiovascular outcomes? Expert Opinion on Pharmacotherapy, 8(15), pp. 2665-2669.
Number of citations in Scopus 2
Number of citations in Web of Science® 3

Doggrell, Sheila (2007) Is fingolimod an advancement in the treatment of multiple sclerosis? Expert Opinion on Pharmacotherapy, 8(3), pp. 383-386.
Number of citations in Scopus 3
Number of citations in Web of Science® 2

Doggrell, Sheila (2007) Misoprostol for the treatment of early pregnancy failure. Current Clinical Pharmacology, 2(1), pp. 1-9.
Number of citations in Scopus 3

Doggrell, Sheila (2007) Novel drugs and products in neuroscience: highlights from IBRO. Drugs of the Future, 32(11), pp. 1007-1017.

Doggrell, Sheila (2007) Rosiglitazone: rosy news for a thiazolidinedione. Expert Opinion on Pharmacotherapy, 8(2), pp. 265-268.
Number of citations in Scopus 1

Doggrell, Sheila (2006) After the failure of citalopram for depression, what next? Expert Opinion on Pharmacotherapy, 7(11), pp. 1515-1518.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2006) Bradykinin B2 receptors as a target in diabetic nephropathy. Current Opinion in Investigational Drugs, 7(3), pp. 251-255.
Number of citations in Scopus 4
Number of citations in Web of Science® 7

Doggrell, Sheila (2006) Ceramide as a target in emphysema. Expert Opinion on Therapeutic Targets, 10(1), pp. 191-194.

Doggrell, Sheila (2006) Inhibition of RANKL: a new approach to the treatment of osteoporosis. Expert Opinion on Pharmacotherapy, 7(8), pp. 1097-1100.
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Doggrell, Sheila (2006) Inhibitors of cholesteryl ester transfer protein - a new approach to coronary artery disease. Expert Opinion on Investigational Drugs, 15(2), pp. 99-106.
Number of citations in Scopus 16
Number of citations in Web of Science® 11

Doggrell, Sheila (2006) Is NXY-059 an advancement in the treatment of acute ischaemic stroke? Expert Opinion on Pharmacotherapy, 7(7), pp. 965-968.

Doggrell, Sheila (2006) Is amlodipine the best initial monotherapy for hypertension? Expert Opinion on Pharmacotherapy, 7(6), pp. 829-832.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2006) Is exenatide advancing the treatment of Type 2 diabetes? Expert Opinion on Pharmacotherapy, 7(1), pp. 109-112.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2006) Muraglitazar: beneficial or detrimental in the treatment of Type 2 diabetes? Expert Opinion on Pharmacotherapy, 7(9), pp. 1229-1233.
Number of citations in Scopus 5
Number of citations in Web of Science® 6

Doggrell, Sheila (2006) Natalizumab in multiple sclerosis: proceed with caution? Expert Opinion on Pharmacotherapy, 7(12), pp. 1675-1678.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) New targets in and potential treatments for cholesterol gallstone disease. Current Opinion in Investigational Drugs, 7(4), pp. 344-348.
Number of citations in Scopus 8
Number of citations in Web of Science® 5

Doggrell, Sheila (2006) Nitrone spin on cerebral ischemia. Current Opinion in Investigational Drugs, 7(1), pp. 20-24.
Number of citations in Scopus 6
Number of citations in Web of Science® 5

Doggrell, Sheila (2006) Partial agonism at nicotinic receptors with varenicline - a new approach to smoking cessation. Expert Opinion on Pharmacotherapy, 7(18), pp. 2599-2603.
Number of citations in Scopus 1

Doggrell, Sheila (2006) Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease. Expert Opinion on Pharmacotherapy, 7(4), pp. 485-488.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) Phosphoinositide 3-kinase-gamma as a target in rheumatoid arthritis and systemic lupus. Expert Opinion on Therapeutic Targets, 10(4), pp. 627-630.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) Recent evidence of sustained benefit with exenatide in Type 2 diabetes. Expert Opinion on Pharmacotherapy, 7(14), pp. 2003-2006.
Number of citations in Scopus 7
Number of citations in Web of Science® 6

Doggrell, Sheila (2006) Sibutramine for obesity in adolescents. Expert Opinion on Pharmacotherapy, 7(17), pp. 2435-2438.
Number of citations in Scopus 3
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) 'Simply stunning' - trastuzumab in HER2-positive breast cancer. Expert Opinion on Pharmacotherapy, 7(5), pp. 631-634.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2006) Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation. Expert Opinion on Pharmacotherapy, 7(2), pp. 225-228.
Number of citations in Scopus 2

Doggrell, Sheila (2006) Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention? Expert Opinion on Pharmacotherapy, 7(15), pp. 2169-2173.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2005) Aspirin and esomeprazole are superior to clopidogrel in preventing recurrent ulcer bleeding. Expert Opinion on Pharmacotherapy, 6(7), pp. 1253-1256.
Number of citations in Scopus 6
Number of citations in Web of Science® 3

Doggrell, Sheila (2005) BG-9928 (Biogen Idec). Current Opinion in Investigational Drugs, 6(9), pp. 962-968.
Number of citations in Scopus 9

Doggrell, Sheila (2005) BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia. Expert Opinion on Investigational Drugs, 14(1), pp. 89-91.
Number of citations in Scopus 33
Number of citations in Web of Science® 30

Doggrell, Sheila (2005) Berberine - a novel approach to cholesterol lowering. Expert Opinion on Investigational Drugs, 14(5), pp. 683-685.
Number of citations in Scopus 40
Number of citations in Web of Science® 34

Doggrell, Sheila (2005) Bradykinin B2 receptors - a target in diabetic nephropathy. Expert Opinion on Therapeutic Targets, 9(2), pp. 411-414.
Number of citations in Scopus 5
Number of citations in Web of Science® 5

Doggrell, Sheila (2005) CHARMed - the effects of candesartan in heart failure. Expert Opinion on Pharmacotherapy, 6(3), pp. 513-516.
Number of citations in Scopus 2

Doggrell, Sheila (2005) CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarction. Expert Opinion on Pharmacotherapy, 6(10), pp. 1761-1764.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2005) Calmodulin kinase II as a target for inhibition in cardiac disease. Expert Opinion on Therapeutic Targets, 9(6), pp. 1319-1321.

Doggrell, Sheila & Wanstall, Janet (2005) Cardiac chymase: pathophysiological role and therapeutic potential of chymase inhibitors. Canadian Journal of Physiology and Pharmacology, 83(2), pp. 123-130.
Number of citations in Scopus 33
Number of citations in Web of Science® 28

Doggrell, Sheila (2005) Clinical evidence for drug treatments in obesity in hypertensive patients. Methods and Findings in Experimental and Clinical Pharmacology, 27(2), pp. 119-125.
Number of citations in Scopus 5
Number of citations in Web of Science® 5

Doggrell, Sheila (2005) Clinical potential of nitric oxide-independent soluble guanylate cyclase activators. Current Opinion in Investigational Drugs, 6(9), pp. 874-878.
Number of citations in Scopus 11

Doggrell, Sheila (2005) Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction. Expert Opinion on Pharmacotherapy, 6(1), pp. 75-84.
Number of citations in Scopus 34
Number of citations in Web of Science® 26

Doggrell, Sheila (2005) Conivaptan (Yamanouchi). Current Opinion in Investigational Drugs, 6(3), pp. 317-326.
Number of citations in Scopus 7

Doggrell, Sheila (2005) Cytochrome P-450: a new target in the heart and coronary circulation. Drugs of the Future, 30(3), pp. 261-269.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Wanstall, Janet, Homer, Kerry, & Doggrell, Sheila (2005) Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets. Current Vascular Pharmacology, 3(1), pp. 41-53.
Number of citations in Scopus 57

Doggrell, Sheila (2005) Farnesoid X receptor agonism - a new approach to the treatment of cholesterol gallstone disease. Expert Opinion on Investigational Drugs, 14(4), pp. 535-538.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2005) Fluoxetine - do the benefits outweigh the risks in adolescent major depression? Expert Opinion on Pharmacotherapy, 6(1), pp. 147-150.
Number of citations in Scopus 6
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved? Expert Opinion on Pharmacotherapy, 6(5), pp. 831-834.
Number of citations in Scopus 6
Number of citations in Web of Science® 2

Doggrell, Sheila & Hancox, Jules (2005) Ibutilide - recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation. Expert Opinion on Investigational Drugs, 14(5), pp. 655-669.
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Is AMN-107 a step forward from imatinib in the treatment of chronic myeloid leukaemia? Expert Opinion on Investigational Drugs, 14(8), pp. 1063-1066.
Number of citations in Scopus 6
Number of citations in Web of Science® 5

Doggrell, Sheila (2005) Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity? Expert Opinion on Pharmacotherapy, 6(12), pp. 2141-2144.

Doggrell, Sheila (2005) More support for high-dose atorvastatin in coronary artery disease. Expert Opinion on Pharmacotherapy, 6(13), pp. 2365-2368.

Doggrell, Sheila (2005) NF-(kappa)B - a target in the inflammation of bone destruction. Expert Opinion on Therapeutic Targets, 9(1), pp. 191-193.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2005) Neuromedin U - a new target in obesity. Expert Opinion on Therapeutic Targets, 9(4), pp. 875-877.
Number of citations in Scopus 8
Number of citations in Web of Science® 6

Doggrell, Sheila (2005) New drugs being developed for the treatment of tuberculosis. Expert Opinion on Investigational Drugs, 14(7), pp. 917-920.
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration. Expert Opinion on Pharmacotherapy, 6(8), pp. 1421-1423.
Number of citations in Scopus 40
Number of citations in Web of Science® 35

Doggrell, Sheila (2005) Phosphodiesterase 5A as a target in cardiac disease. Expert Opinion on Therapeutic Targets, 9(5), pp. 1097-1100.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2005) Potential of growth hormone-releasing hormone antagonists (JV-1-36 and JV-1-42) for the treatment of brain tumours. Expert Opinion on Investigational Drugs, 14(12), pp. 1561-1564.

Doggrell, Sheila (2005) Pregabalin or morphine and gabapentin for neuropathic pain. Expert Opinion on Pharmacotherapy, 6(14), pp. 2535-2539.
Number of citations in Scopus 8
Number of citations in Web of Science® 6

Doggrell, Sheila (2005) Recent findings with docetaxel in postoperative treatment for breast cancer. Expert Opinion on Pharmacotherapy, 6(16), pp. 2903-2906.

Doggrell, Sheila (2005) Recent important trials of pharmacotherapy in Parkinson's disease. Expert Opinion on Pharmacotherapy, 6(6), pp. 1025-1028.

Doggrell, Sheila (2005) Relating statin therapy to C-reactive protein levels. Expert Opinion on Pharmacotherapy, 6(9), pp. 1597-1600.
Number of citations in Scopus 7
Number of citations in Web of Science® 7

Doggrell, Sheila (2005) Rho-kinase inhibitors show promise in pulmonary hypertension. Expert Opinion on Investigational Drugs, 14(9), pp. 1157-1159.
Number of citations in Scopus 24
Number of citations in Web of Science® 21

Doggrell, Sheila (2005) Stabilisation of calstabin2 - a new approach in sudden cardiac death. Expert Opinion on Therapeutic Targets, 9(5), pp. 955-962.
Number of citations in Scopus 4
Number of citations in Web of Science® 3

Doggrell, Sheila (2005) Taking the 20-HETE out of the cardiovascular system: The potential of 20-HETE synthesis inhibitors. Current Opinion in Investigational Drugs, 6(9), pp. 901-906.
Number of citations in Scopus 2

Doggrell, Sheila (2005) Which drug combination for hormone-refractory prostate cancer? Expert Opinion on Pharmacotherapy, 6(4), pp. 667-670.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2005) Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant? Expert Opinion on Investigational Drugs, 14(3), pp. 339-342.
Number of citations in Scopus 13
Number of citations in Web of Science® 7

Doggrell, Sheila (2005) Ximelagatran - recent comparisons with warfarin. Expert Opinion on Pharmacotherapy, 6(11), pp. 1943-1946.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2005) The nitrosterols - a step forward from the steroid anti-inflammatory drugs? Expert Opinion on Investigational Drugs, 14(7), pp. 823-828.
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) The safety of lumiracoxib when used in the treatment of arthritis. Expert Opinion on Pharmacotherapy, 6(2), pp. 347-350.
Number of citations in Scopus 11
Number of citations in Web of Science® 7

Doggrell, Sheila (2005) A small-molecule lead compound for the treatment of Alzheimer's disease. Expert Opinion on Investigational Drugs, 14(2), pp. 199-201.

Conference Paper

Doggrell, Sheila A. & Schaffer, Sally (2016) Lack of recall of bioscience knowledge by nursing students. In Proceedings of the Australian Conference on Science and Mathematics Education, University of Queensland, St Lucia Campus, Brisbane, QLD.
Number of full-text downloads 10

Schaffer, Sally, Doggrell, Sheila, & Polkinghorne, Adam (2013) Continuing success of a strategy to support accelerated nursing students at two diverse campuses. In First Year Higher Education (FYHE 2013), 7-10 July 2013, Museum of New Zealand Te Papa Tongarewa, Wellington.
Number of full-text downloads 37

Doggrell, Sheila A. (2012) Writing eBooks to support first year students. In First Year in Higher Education Conference, 6 July 2007, Queensland University of Technology, Brisbane, Queensland, Australia.
Number of full-text downloads 184

Doggrell, Sheila A. & Polkinghorne, Adam (2011) A Strategy for supporting students given Advanced Standing into Nursing. In Thomas, Jason (Ed.) 14th Pacific Rim First Year in Higher Education Conference 2011 : Design for Student Success, Colourwise Reproductions, Freemantle, Western Australia.
Number of full-text downloads 25

Conference Item

Devine, Christine & Doggrell, Sheila (2016) Learning together: Group support sessions for pharmacology and their evaluation. In Australian Conference on Science and Mathematics Education, 28-30 September 2016, University of Queensland, Brisbane, Qld.
Number of full-text downloads 4

Doggrell, Sheila, Schaffer, Sally, Rowe, Jillian L., & Prasolova, Nina (2015) “Success in (Surviving) Bioscience and Pharmacology” – an eBook to improve the retention of diploma nurses transitioning to a Bachelor of Nursing course. In Student Success Symposium, 18 November 2015, Brisbane, QLD. (Unpublished)
Number of full-text downloads 20

Doggrell, Sheila, Menzies, Victoria, & Bakon, Shannon (2015) Peer leader led revision skills workshop – who benefits? In STARS: Students, Transitions, Achievements, Retention and Success, 1 - 4 July 2015, Melbourne, Vic. (Unpublished)
Number of full-text downloads 93

Doggrell, Sheila A. (2015) Reduced attrition of accelerated nursing students from pharmacology – is it associated with graduation? In STARS: Students, Transitions, Achievement, Retention and Success, 1 - 4 July 2015, Melbourne, Vic.
Number of full-text downloads 6

Doggrell, Sheila A. & Schaffer, Sally (2015) Which accelerated nursing students withdraw and fail in their first year of a Bachelor of Nursing (BN)? In STARS: Students, Transitions, Achievement, Retention and Success, 1 - 4 July 2015, Melbourne, Vic.
Number of full-text downloads 6

Schaffer, Sally, Doggrell, Sheila, Polkinghorne, Adam, & Tuli, Rinku (2014) A loss of bioscience knowledge in nursing students. In ANZAHPE 2014 Annual Conference of the Australian and New Zealand Association for Health Professional Educators, 7-10 July 2014, Gold Coast, Australia. (Unpublished)
Number of full-text downloads 96

Doggrell, Sheila, Schaffer, Sally, Polkinghorne, Adam, & Tuli, Rinku (2014) Do nursing students have the recall of bioscience necessary to study pharmacology? In 17th World Congress of Basic and Clinical Pharmacology (WCP2014), 13-18 July 2014, Cape Town, South Africa.

Doggrell, Sheila, Polkinghorne, Adam, Schaffer, Sally, Ekberg, Jenny, Pavasovic, Ana, & Wightman, Bradley (2013) Exploring the recall of Bioscience knowledge amongst nursing students. In First Year Higher Education (FYHE 2013), 7-10 July 2013, Museum of New Zealand Te Papa Tongarewa, Wellington. (Unpublished)
Number of full-text downloads 27

Doggrell, Sheila A., Schaffer, Sally, & Polkinghorne, Adam (2013) Surviving Bioscience and Pharmacology – an eBook for accelerated students in Nursing. In 16th International First Year Higher Education Conference 2013, 7-10 July 2013, Museum of New Zealand Te Papa Tongarewa, Wellington, New Zealand.
Number of full-text downloads 146

Doggrell, Sheila Anne, Schaffer, Sally, & Dallemagne, Catherine (2012) Transferring a successful strategy for supporting accelerated nursing students from a small to a large cohort. In Nelson, Karen J. & Kift, Sally M. (Eds.) 15th International First Year in Higher Education Conference : New Horizons, 26-29 June 2012, Sofitel Brisbane Central, Brisbane, QLD.
Number of full-text downloads 88

Polkinghorne, Adam & Doggrell, Sheila (2012) A successful strategy for supporting low socioeconomic and accelerated students studying Biosciences in their first year of study. In Mortimer, Rachel (Ed.) 15th International First Year in Higher Education Conference 2012 : New Horizons, 26 - 29 June 2012, Sofitel Brisbane Central, Brisbane, Queensland, Australia.
Number of full-text downloads 41

Review

Other

Doggrell, Sheila (2012) Drugs and local chemical mediators. Pharmacology in One Semester.
Number of full-text downloads 132

Doggrell, Sheila (2012) Drugs and neurotransmitters. Pharmacology in One Semester.
Number of full-text downloads 146

Doggrell, Sheila (2012) Drugs and the gastrointestinal tract. Pharmacology in One Semester. (Unpublished)
Number of full-text downloads 218

Doggrell, Sheila (2012) Drugs and the somatic nervous system. Pharmacology in One Semester.
Number of full-text downloads 67

Doggrell, Sheila (2012) Drugs for cardiac arrhythmmias, antithrombotic drugs and lipid modulating drugs. Pharmacology in one semester.
Number of full-text downloads 219

Doggrell, Sheila (2012) Drugs for diabetes and obesity. Pharmacology in one semester.
Number of full-text downloads 115

Doggrell, Sheila (2012) Drugs for hypertension, angina and heart failure. Pharmacology in One Semester.
Number of full-text downloads 200

This list was generated on Sun May 21 07:31:02 2017 AEST.